KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Interest Expenses (2016)

AbbVie (ABBV) has disclosed Interest Expenses for 5 consecutive years, with $245.0 million as the latest value for Q2 2016.

  • Quarterly Interest Expenses rose 42.44% to $245.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $245.0 million through Mar 2017, down 69.45% year-over-year, with the annual reading at $719.0 million for FY2015, 67.6% up from the prior year.
  • Interest Expenses for Q2 2016 was $245.0 million at AbbVie, up from $215.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $245.0 million in Q2 2016, with the low at $10.0 million in Q3 2012.
  • Average Interest Expenses over 5 years is $125.8 million, with a median of $113.0 million recorded in 2012.
  • Peak annual rise in Interest Expenses hit 650.0% in 2013, while the deepest fall reached 21.28% in 2013.
  • Over 5 years, Interest Expenses stood at $94.0 million in 2012, then dropped by 21.28% to $74.0 million in 2013, then surged by 87.84% to $139.0 million in 2014, then soared by 49.64% to $208.0 million in 2015, then grew by 17.79% to $245.0 million in 2016.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $245.0 million, $215.0 million, and $208.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.